Biologics and Biosimilars for Moderate-to-severe Psoriasis Biologics and Biosimilars for Moderate-to-severe Psoriasis

This study compares long-term safety, efficacy, and drug survival data on these agents.The British Journal of Dermatology

Source: Medscape Today Headlines - April 12, 2018 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news